Christopher Morabito
Director Técnico/Científico/I+D en ASTRIA THERAPEUTICS, INC. .
Fortuna: - $ al 31/05/2024
Cargos activos de Christopher Morabito
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 15/07/2022 | - |
Historial de carrera de Christopher Morabito
Antiguos cargos conocidos de Christopher Morabito.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 10/05/2021 | 13/07/2022 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Director Técnico/Científico/I+D | 01/10/2016 | 01/07/2020 |
| MERCK & CO., INC. | Director/Miembro de la Junta | 01/10/2010 | 01/04/2014 |
Cardurion Pharmaceuticals LLC
 Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Director Técnico/Científico/I+D | - | - |
Formación de Christopher Morabito.
| Franklin & Marshall College | Undergraduate Degree |
| Penn State Hershey College of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Japón | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Morabito
- Experiencia
